Pancreatic Cancer Research

ResearcherTang Du HospitalNo recent work listed

Yongdong Guo

Verified by OpenAlex author ID (good confidence, 0.85), identity_conf@1As of 7 November 2026

Matched on OpenAlex author ID A5028561588. Sources: OpenAlex.

Their work

Papers
6 (first author 1, last author 0)
Trials
0
Grants
0
Labs led
0
Collaborators
7
Papers, trials and grants by year

2021: 1 paper · 2022: 2 papers · 2023: 3 papers

Papers 6

  1. AKR7A3 modulates the metastasis of pancreatic ductal adenocarcinoma through regulating PHGDH-suppressed autophagy. Co-author DOI 10.1111/cas.15798↗
  2. Machine learning-based integration develops a metabolism-derived consensus model for improving immunotherapy in pancreatic cancer. Co-author DOI 10.1136/jitc-2023-007466↗
  3. Correction: TMEM43 promotes pancreatic cancer progression by stabilizing PRPF3 and regulating RAP2B/ERK axis. Co-author DOI 10.1186/s11658-023-00419-y↗
  4. TMEM43 promotes pancreatic cancer progression by stabilizing PRPF3 and regulating RAP2B/ERK axis. Co-author DOI 10.1186/s11658-022-00321-z↗
  5. Comprehensive Analysis of 5-Methylcytosine (m5C) Regulators and the Immune Microenvironment in Pancreatic Adenocarcinoma to Aid Immunotherapy. First author DOI 10.3389/fonc.2022.851766↗
  6. Comprehensive Analysis of m6A RNA Methylation Regulators and the Immune Microenvironment to Aid Immunotherapy in Pancreatic Cancer. Co-author DOI 10.3389/fimmu.2021.769425↗

Closest collaborators

The 7 strongest of 7 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Ronglin Wang · 6 shared papers, 2021–2023 · strength 0.84
  2. Haichuan Su · 6 shared papers, 2021–2023 · strength 0.84
  3. Lei Hua · 5 shared papers, 2021–2023 · strength 0.69
  4. Junqiang Li · 4 shared papers, 2021–2023 · strength 0.52
  5. Yang Song · 3 shared papers, 2021–2023 · strength 0.39
  6. Cheng Yang · 3 shared papers, 2021–2022 · strength 0.37
  7. Ting Zhao · 2 shared papers, 2021–2022 · strength 0.24

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.